Table 2.

Genotype and allele frequencies association analysis of MASP2, TLR1, CTLA4, and C11orf30 in the study subjects.

Gene	SNP	Allele/genotype	Control (n, %)	AA patients (n, %)	P-value
CTLA4	rs12622799	C	217, 74	224, 74	0.13
		T	77, 26	80, 26
		C/C	84, 57	84, 55	0.76
		C/T	49, 33	56, 37
		T/T	14, 10	12, 8
	rs12990970	C	161, 55	162, 53	0.2
		T	131, 45	142, 47
		C/C	45, 31	48, 32	0.58
		C/T	71, 49	66, 43
		T/T	30, 21	38, 25
	rs1427678	A	149, 51	158, 52	0.25
		G	145, 49	146, 48
		A/A	39, 27	45, 30	0.79
		A/G	71, 48	68, 45
		G/G	37, 25	39, 26
	rs231726	C	221, 76	230, 76	0.64
		T	71, 24	74, 24
		C/C	83, 57	89, 59	0.72
		C/T	55, 38	52, 34
		T/T	8, 5	11, 7
	rs231775	A	192, 66	211, 69	0.42
		G	98, 34	93, 31
		A/A	64, 44	76, 50	0.59
		A/G	64, 44	59, 39
		G/G	17, 12	17, 11
	rs3087243	G	160, 54	161, 53	0.13
		A	134, 46	143, 47
		A/A	31, 21	40, 26	0.38
		G/A	72, 49	63, 41
		G/G	44, 30	49, 32
TLR1	rs117033348	A	296, 100	304, 100	Monomorphic
	rs4833095	C	167, 57	175, 58	0.044
		T	125, 43	129, 42
		C/C	54, 37	53, 35	0.67
		C/T	59, 40	69, 45
		T/T	33, 23	30, 20
	rs5743557	G	201, 68	198, 65	0.44
		A	93, 32	106, 35
		A/A	18, 12	18, 12	0.42
		G/A	57, 39	70, 46
		G/G	72, 49	64, 42
MASP2	rs2273346	A	274, 93	293, 96	0.22
		G	22, 7	11, 4
		A/A	126, 85	143, 94	0.0026
		A/G	22, 15	7, 5
		G/G	0, 0	2, 1
C11orf30	rs2155219	T	165, 57	137, 45	0.49
		G	123, 43	165, 55
		G/G	22, 15	45, 30	0.0069
		T/G	79, 55	75, 50
		T/T	43, 30	31, 21